<SEC-DOCUMENT>0001493152-20-009957-index.html : 20200527
<SEC-HEADER>0001493152-20-009957.hdr.sgml : 20200527
<ACCEPTANCE-DATETIME>20200527180152
ACCESSION NUMBER:		0001493152-20-009957
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200522
FILED AS OF DATE:		20200527
DATE AS OF CHANGE:		20200527

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Kruger Kurt H
		CENTRAL INDEX KEY:			0001375881

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37428
		FILM NUMBER:		20916457

	MAIL ADDRESS:	
		STREET 1:		100 FOXBOROUGH BLVD
		STREET 2:		SUITE 240
		CITY:			FOXBOROUGH
		STATE:			MA
		ZIP:			02035

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Qualigen Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001460702
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				263474527
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1880 CENTURY PARK EAST, SUITE 1000
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067
		BUSINESS PHONE:		310-203-1000

	MAIL ADDRESS:	
		STREET 1:		1880 CENTURY PARK EAST, SUITE 1000
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RITTER PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20090402
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>